Development of Quantitative Parameter of Upper Extremity Function in Patients With Brain Disorder Using Smart-Board and Smart-Glove.

February 5, 2026 updated by: Won Hyuk Chang, Samsung Medical Center

Development of Quantitative Parameter of Upper Extremity Function in Patients With Brain Disorder Using Smart-Board and Smart-Glove, Single-Center, Prospective Study

The aim of this study is to develop a novel quantitative metric for assessing upper-limb function in patients with neurological disorders. This will be accomplished by analyzing performance data obtained from a smart board and smart glove system and comparing these data with conventional clinical assessment methods currently used to evaluate upper-limb impairment.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • South Korea
      • Seoul, South Korea
        • Samsung Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 19 years or older.
  • Patients with upper-limb functional impairment due to neurological conditions such as stroke, cerebral palsy, brain tumor, traumatic brain injury, or Parkinson's disease.

Exclusion Criteria:

  • Patients with progressive neurological disorders or those in a state of hemodynamic instability.
  • Patients with severe cognitive impairment (MMSE < 10) or significant communication difficulty due to language disorders.
  • Any other condition in which the investigator determines that participation in the study is inappropriate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Smart Device User
Device: smart device
Participants will undergo two sessions of upper-limb movement assessment using the smart board and smart glove on the day of the clinical trial. Simultaneously, video recordings will be obtained using a mobile camera. These procedures will be used to collect quantitative data on upper-limb movements.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
validity
Time Frame: the day of the study procedures
To examine the correlation between the primary outcome measure (FM-UE) and the trunk rehabilitation assessment model derived from mobile camera, smart board, and smart glove data.
the day of the study procedures

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Samsung Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 7, 2024

Primary Completion (Actual)

December 23, 2025

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

January 20, 2026

First Submitted That Met QC Criteria

February 5, 2026

First Posted (Actual)

February 9, 2026

Study Record Updates

Last Update Posted (Actual)

February 9, 2026

Last Update Submitted That Met QC Criteria

February 5, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023-11-105
  • RS-2023-00248118 (Other Grant/Funding Number: Korea Medical Device Development Fund)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain Disorder

Clinical Trials on smart device

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe